GEN Exclusives

More »

GEN News Highlights

More »
May 11, 2007

DermTech to Supply Technology to Develop Compounds for Skin Conditions

  • Researchers from DermTech and three California medical institutes reported a collaboration to explore the development of products for skin-related conditions, including signs of aging and atopic dermatitis.

    "Our research group has been interested in the role of the permeability barrier in skin disorders, including attenuating the effects of atopic dermatitis and aging for some time," states W.M. Holleran, University of California San Francisco (UCSF), one of the participants. “DermTech's noninvasive, molecular basis for assessing skin status represents a key addition to enhance our research efforts in these areas.”

    DermTech will provide its EGIR (RNA tape stripping and assay development) technology to scientists from the Department of Dermatology, School of Medicine, UCSF, the Northern California Institute for Research and Education (NCIRE), and the Department of Veterans Affairs Medical Center San Francisco.

    The researchers will work together to identify novel therapeutic compounds for certain skin disorders, formulations that will arrest or ameliorate the dermatological effects of aging, biomarkers involved in dermatological disorders and aging, and gene expression patterns predictive of patient responsiveness to drug treatment.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?